RecruitingPhase 2NCT05180097

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Studying Classic Hodgkin lymphoma

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Canadian Cancer Trials Group
Principal Investigator: Kerry Savage
BCCA-Vancouver Cancer Centre
Intervention: Gemcitabine(drug)
Enrollment: 84 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2026

Study locations (18)

Concord Repatriation General Hospital, Concord, New South Wales, Australia
Shoalhaven Cancer Care Centre, Nowra, New South Wales, Australia
Wollongong Hospital, Wollongong, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Austin Hospital, Heidelberg, Victoria, Australia
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
BCCA - Vancouver, Vancouver, British Columbia, Canada
Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
London Health Sciences Centre Research Inc., London, Ontario, Canada
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
University Health Network, Toronto, Ontario, Canada
The Jewish General Hospital, Montreal, Quebec, Canada
+3 more locations on ClinicalTrials.gov

Collaborators

Merck Sharp & Dohme LLC · Pfizer · Australasian Leukaemia and Lymphoma Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05180097 on ClinicalTrials.gov

Other trials for Classic Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Classic Hodgkin lymphoma →

← Back to all trials